亚太药业
(002370)
| 流通市值：38.18亿 | | | 总市值：38.18亿 |
| 流通股本：7.46亿 | | | 总股本：7.46亿 |
| 利润表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 营业总收入 | 157,522,506.43 | 59,576,342.35 | 323,136,959.51 | 228,305,775.2 |
| 营业总成本 | 151,041,056.27 | 61,867,871.14 | 368,315,692.88 | 281,658,163.74 |
| 其他经营收益 | | | | |
| 营业利润 | -1,388,274.84 | -2,796,416.41 | 90,508,353.26 | 97,259,904.67 |
| 利润总额 | -1,014,574.02 | -2,843,180.2 | 96,432,340.46 | 97,121,104.22 |
| 净利润 | -516,346.76 | -2,587,529.71 | 96,307,827.65 | 97,195,012.22 |
| 每股收益 | | | | |
| 其他综合收益 | - | - | - | - |
| 综合收益总额 | -516,346.76 | -2,587,529.71 | 96,307,827.65 | 97,195,012.22 |
| 资产负债表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 流动资产: | | | | |
| 流动资产合计 | 794,811,771.17 | 858,057,073.26 | 898,274,346.36 | 815,983,271 |
| 非流动资产: | | | | |
| 非流动资产合计 | 397,066,457.54 | 374,829,134.07 | 381,441,669.53 | 397,963,742.65 |
| 资产总计 | 1,191,878,228.71 | 1,232,886,207.33 | 1,279,716,015.89 | 1,213,947,013.65 |
| 流动负债: | | | | |
| 流动负债合计 | 62,547,079.04 | 108,530,650.5 | 152,236,749.52 | 79,457,842.51 |
| 非流动负债: | | | | |
| 非流动负债合计 | 5,557,829.11 | 6,653,419.22 | 7,192,383.05 | 13,315,103.25 |
| 负债合计 | 68,104,908.15 | 115,184,069.72 | 159,429,132.57 | 92,772,945.76 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 1,119,854,192.86 | 1,117,702,137.61 | 1,120,286,883.32 | 1,121,174,067.89 |
| 股东权益合计 | 1,123,773,320.56 | 1,117,702,137.61 | 1,120,286,883.32 | 1,121,174,067.89 |
| 负债和股东权益合计 | 1,191,878,228.71 | 1,232,886,207.33 | 1,279,716,015.89 | 1,213,947,013.65 |
| 现金流量表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 106,892,284.38 | 49,795,880.47 | 275,734,814.73 | 183,049,891.24 |
| 经营活动现金流出小计 | 175,105,213.65 | 51,994,772.28 | 246,838,452.62 | 159,500,933.06 |
| 经营活动产生的现金流量净额 | -68,212,929.27 | -2,198,891.81 | 28,896,362.11 | 23,548,958.18 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 112,961,707.5 | 20,110,169.06 | 239,197,752.33 | 209,132,163.04 |
| 投资活动现金流出小计 | 152,078,674.55 | 51,983,027.33 | 65,052,612.63 | 64,351,564.63 |
| 投资活动产生的现金流量净额 | -39,116,967.05 | -31,872,858.27 | 174,145,139.7 | 144,780,598.41 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | 4,000,000 | - | - | - |
| 筹资活动现金流出小计 | - | - | 314,596,678.34 | 314,596,678.34 |
| 筹资活动产生的现金流量净额 | 4,000,000 | - | -314,596,678.34 | -314,596,678.34 |
| 汇率变动对现金及现金等价物的影响 | - | - | - | - |
| 现金及现金等价物净增加额 | -103,329,896.32 | -34,071,750.08 | -111,555,176.53 | -146,267,121.75 |
| 期末现金及现金等价物余额 | 504,813,650.41 | 574,071,796.65 | 608,143,546.73 | 573,431,601.51 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | -103,329,896.32 | - | -111,555,176.53 | - |